Details werden geladen...
First-of-its-kind flu vaccine could be coming as FDA panel weighs historic shot
Moderna is seeking Food and Drug Administration approval of its new shot, dubbed mFlusiva, as an option for people 50 and older. The FDA advisory committee meeting is a step toward a final decision…
Ähnliche Seiten
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology | The Manila Times
https://www.manilatimes.net/2026/06/19/world/fda-panel-considers-a-first-of-its-kind-flu-vaccine-using-mrna-technology/2368764
FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy - The Boston Globe
https://www.bostonglobe.com/2026/06/18/business/fda-advisory-panel-endorses-moderna-mrna-flu-vaccine/
FDA panel backs first-of-its-kind flu vaccine using mRNA technology - Los Angeles Times
https://www.latimes.com/science/story/2026-06-19/fda-panel-backs-first-of-its-kind-flu-vaccine-using-mrna-technology
FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy
https://www.statnews.com/2026/06/18/fda-mrna-flu-vaccine-vrbpac-advisers-endorse-moderna-shots/
U.S. FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
https://www.ctvnews.ca/health/article/us-fda-panel-considers-a-first-of-its-kind-flu-vaccine-using-mrna-technology/